Download Tripanosomiasis americana (Enfermedad de

Capítulo 279 Tripanosomiasis americana (Enfermedad de Chagas; Trypanosoma cruzi) & e279-1
BIBLIOGRAFÍA
© ELSEVIER. Fotocopiar sin autorización es un delito.
Bern C, Montgomery SP: An estimate of the burden of Chagas disease in
the United States, Clin Infect Dis 49:e52-e54, 2009.
Bern C, Montgomery SP, Herwaldt BL, et al: Evaluation and treatment
of Chagas disease in the United States: a systematic review, JAMA
298:2171-2181, 2007.
Chessler AD, Ferreira LR, Chang TH, et al: A novel IFN regulatory
factor 3-dependent pathway activated by trypanosomes triggers
IFN-beta in macrophages and fibroblasts, J Immunol 181:79177924, 2008.
Dias JC, Dias E, Filho OM, et al: Further evidence of spontaneous cure
in human Chagas disease, Rev Soc Bras Med Trop 41:505-506,
2008.
Jannin J, Villa L: An overview of Chagas disease treatment, Mem Inst
Oswaldo Cruz 102:S95-S97, 2007.
Médecins Sans Frontières International meeting: new diagnostic tests
are urgently needed to treat patients with Chagas disease. Campaign
for Access to Essential Medicines, Rev Soc Bras Med Trop 41:315-319,
2008.
Medei EH, Nascimento JH, Pedrosa RC, et al: Role of autoantibodies in
the physiopathology of Chagas’ disease, Arq Bras Cardiol 91:
257-262, 281-286, 2008.
Milei J, Guerri-Guttenberg RA, Grana DR, et al: Prognostic impact of
Chagas disease in the United States, Am Heart J 157:22-29, 2009.
Rassi A Jr, Rassi A, Marin-Neto JA: Chagas disease, Lancet 375:13881400, 2010.
Salazar-Schettino PM, Perera R, Ruiz-Hernandez AL, et al: Chagas
disease as a cause of symptomatic chronic myocardiopathy in
Mexican children, Pediatr Infect Dis J 28:1011-1012, 2009.
Villar JC, Marin-Neto JA, Ebrahim S, et al: Trypanocidal drugs for
chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev 1:CD003463, 2002.
Yadon ZE, Schmunis GA: Congenital Chagas disease: estimating the
potential risk in the United States, Am J Trop Med Hyg 81:927-933,
2009.